[1] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志,2020,35(9):833-854. DOI:10.3969/j.issn.1000-3614.2020.09.001.
[2] Libby P, Pasterkamp G, Crea F, et al. Reassessing the mechanisms of acute coronary syndromes[J].Circ Res,2019, 124(1):150-160. DOI: 10.1161/CIRCRESAHA.118. 311098.
[3] 文贤慧,张军华,桂嵘.不同状态下血栓弹力图与凝血功能、血小板数关系的探讨[J].中国实验血液学杂志,2018,26(06):1793-1799. DOI:0.7534/j.issn.1009-2137.2018. 06.035.
[4] 中国医师协会急诊医师分会,国家卫健委能力建设与继续教育中心急诊学专家委员会,中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019)[J]. 中国急救医学,2019,39(4):301-308. DOI:10.3969/j.issn.1002-1949.2019.04.001.
[5] Buljubasic N, Akkerhuis KM, Cheng JM, et al. Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography[J]. Coron Artery Dis, 2017,28(1):23-32. DOI: 10.1097/MCA.0000000000000442.
[6] Ząbczyk M, Natorska J, Undas A. Fibrin clot properties in atherosclerotic vascular disease: from pathophysiology to clinical outcomes[J]. J Clin Med, 2021,10(13):2999. DOI: 10.3390/jcm10132999.
[7] Surma S, Banach M. Fibrinogen and atherosclerotic cardiovascular diseases-review of the literature and clinical studies[J]. Int J Mol Sci, 2021,23(1):193. DOI: 10.3390/ijms23010193.
[8] Yang Y, Li G, Zhang R. Correlation analysis of acute coronary syndrome with serum IL-18, MMP-9, hs-CRP, and plasma FIB[J]. Biomed Res Int, 2022,2022: 5984184. DOI: 10.1155/2022/5984184.
[9] Song J, Yu T, Sun Z, et al. Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention[J]. Coron Artery Dis, 2020,31(2):124-129. DOI: 10.1097/MCA.0000000000000789.
[10] Ang L, Behnamfar O, Palakodeti S, et al. Elevated baseline serum fibrinogen: effect on 2-year major adverse cardiovascular events following percutaneous coronary intervention[J]. J Am Heart Assoc, 2017, 6(11):e006580. DOI: 10.1161/JAHA.117.006580.
[11] Mahmud E, Ramsis M, Behnamfar O, et al. Effect of serum fibrinogen, total stent length, and type of acute coronary syndrome on 6-month major adverse cardiovascular events and bleeding after percutaneous coronary intervention[J]. Am J Cardiol, 2016,117(10):1575-1581. DOI: 10.1016/j.amjcard.2016.02.032.
[12] 穆利英,吴昱,孟帅,等. 纤维蛋白原与急性冠脉综合征患者冠状动脉病变严重程度的关系研究[J]. 实用心脑肺血管病杂志,2020,28(2):23-26. DOI:10.3969/j.issn.1008-5971. 2020.02.006.
[13] Peng Y, Xia TL, Li YM, et al. Fibrinogen is related to longterm mortality in Chinese patients with acute coronary syndrome but fafled to enhance the prognostic value of the GRACE score[J]. Oncotarget, 2017, 8(13): 20622-20629. DOI: 10.18632/oncotarget.15094.
[14] 世界华人检验与病理医师协会,中国医师协会检验医师分会心血管检验医学专业委员会.血小板功能检测在急性冠脉综合征患者抗血小板治疗中的应用专家共识[J].中华医学杂志,2018,98(22):1743-1751. DOI:10.3760/cma.j.issn.0376-2491.2018.22.005.
[15] Yan XQ, Zhang C, Shi HY, et al. Platelet-fibrin clot strength measured by thromboelastography could predict hypercoagulability and antiplatelet effects in patients after percutaneous coronary intervention[J]. Ann Palliat Med, 2021,10(3):2448-2457. DOI: 10.21037/apm-20- 1728.
[16] Kanji R, Kubica J, Navarese EP, et al. Endogenous fibrinolysis-relevance to clinical thrombosis risk assessment[J]. Eur J Clin Invest, 2021, 51(4): e13471. DOI: 10.1111/eci.13471.
[17] Zeng X, Fang L, Peng Y, et al. A multicenter reference interval study of thromboelastography in the Chinese adult population[J]. Thromb Res, 2020,195:180-186. DOI: 10.1016/j.thromres.2020.07.019.
[18] 杨渊博,杨建章.血栓弹力图对急性冠状动脉综合征患者的诊断价值[J].血栓与止血学,2021,27(3):365-367.DOI:10.3969/j.issn.1009-6213.2021.03.002.
[19] 孔庆瑞,赵云兰,林萍,等. 急性冠状动脉综合征患者血栓弹力图特征及临床意义研究[J]. 国际心血管病杂志,2019,46(3):179-182. DOI:10.3969/j.issn.1673-6583.2019. 03.012.
[20] Wan H, Fan X, Wu Z, et al. Prevalence and impact of fibrinolytic dysregulation in patients with acute coronary syndromes[J]. Thromb J, 2021,19(1):33. DOI: 10.1186/s12959-021-00288-5.
|